Here it’s a little more problematic imho - the drug itself was discovered, designed, patented by Takeda and then licensed. When we start hyphenating “AI” people stop reading after “AI”.
I just had my 9th anniversary and needed ideas. So I told my wife, here is your AI-enabled gift.
@Frank_S_David@MattyKirsh They are certainly taking liberties marketing this as “AI-enabled”. “Among” is doing a lot of work here (likely a lawyer add).
Thrilled to announce $5B in funding for @IsomorphicLabs to accelerate our mission to Solve All Disease. We continue to make rapid progress reimagining drug design from first principles with AI to radically cut the time & cost to find new medicines. Gradually, then all at once...
Well yeah - the Boston definition and West Coast definition is the first divergence. Then you have 1) academic/medical institution discovered and validated, tech transfer to venture creation funds to stealthcos; 2) China discovered and developed and transferred to ventured-wrapped newcos (see Ollin yesterday); and 3) old school, built-this-in-my-garage types (eg Absci), and you see an emergence of these AI native startups in SF/SV (see Convexia and others) led by Stanford grads. I would argue 3 is falls into the classic definition and maybe 1.